Cutera (NASDAQ:CUTR) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a report published on Tuesday. The firm issued a sell rating on the medical device company’s stock.

Cutera Trading Down 4.9 %

Shares of CUTR stock opened at $0.44 on Tuesday. The stock has a 50 day moving average of $0.39 and a 200 day moving average of $0.71. Cutera has a twelve month low of $0.28 and a twelve month high of $3.18. The stock has a market cap of $8.96 million, a P/E ratio of -0.07 and a beta of 1.31.

Cutera (NASDAQ:CUTR) last issued its quarterly earnings data on Thursday, November 7th. The medical device company reported ($1.94) EPS for the quarter, missing the consensus estimate of ($0.96) by ($0.98). The business had revenue of $32.50 million during the quarter, compared to the consensus estimate of $32.57 million. During the same quarter in the prior year, the firm posted ($2.22) earnings per share. On average, research analysts predict that Cutera will post -5.78 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Cutera

An institutional investor recently raised its position in Cutera stock. Bank of Montreal Can increased its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 14.2% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 282,704 shares of the medical device company’s stock after purchasing an additional 35,248 shares during the quarter. Bank of Montreal Can owned approximately 1.41% of Cutera worth $455,000 as of its most recent filing with the SEC. Institutional investors and hedge funds own 90.70% of the company’s stock.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.